MEDPAL AI is trading 5.3% down now at £6.25 after no confirmed company-specific catalyst was identified for September 11, 2026.

  • The latest reported announcement, dated September 9, covered a non-executive director appointment and 40,000,000 CEO options, but did not explain the current decline.
  • The move appears driven by continued volatility after sharp recent gains, while broader markets were higher in the provided context.